Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × venetoclax × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 87 Leukemia, Lymphocytic, Chronic, B-Cell 42 Myelodysplastic Syndromes 27 Leukemia 15 Leukemia, Myelomonocytic, Chronic 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Burkitt Lymphoma 11 Recurrence 9 Lymphoma, Non-Hodgkin 8 Lymphoma, Mantle-Cell 8 Hematologic Neoplasms 8 Lymphoma 7 Leukemia, Biphenotypic, Acute 7 Neoplasms 6 Myeloproliferative Disorders 6 Lymphoma, Large B-Cell, Diffuse 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, B-Cell 4 Waldenstrom Macroglobulinemia 3 Blastic Plasmacytoid Dendritic Cell Neoplasm 3 Anemia, Refractory, with Excess of Blasts 3 Primary Myelofibrosis 2 Lymphoproliferative Disorders 2 Lymphoma, Follicular 2 Leukemia, Myeloid 2 Immunoglobulin Light-chain Amyloidosis 2 Hematologic Diseases 2 Venentoclax 1

Interventions

capivasertib 2 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 copanlisib 1 axicabtagene ciloleucel 1 Receptors, Interleukin-6 1 Interleukin 1 Receptor Antagonist Protein 1 Fulvestrant 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡